X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5859) 5859
Magazine Article (10) 10
Publication (6) 6
Book Chapter (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5185) 5185
male (4261) 4261
female (3820) 3820
middle aged (3032) 3032
albuminuria (2616) 2616
adult (2399) 2399
aged (1918) 1918
albuminuria - physiopathology (1780) 1780
risk factors (1647) 1647
glomerular filtration rate (1621) 1621
microalbuminuria (1442) 1442
diabetic nephropathies - physiopathology (1412) 1412
blood pressure (1408) 1408
endocrinology & metabolism (1393) 1393
urology & nephrology (1270) 1270
hypertension (1208) 1208
kidney - physiopathology (1116) 1116
albuminuria - etiology (1102) 1102
diabetes mellitus, type 2 - physiopathology (1100) 1100
hypertension - physiopathology (1079) 1079
nephropathy (1001) 1001
diabetes mellitus, type 1 - physiopathology (962) 962
animals (921) 921
diabetes (912) 912
prevalence (779) 779
proteinuria (779) 779
albuminuria - urine (775) 775
peripheral vascular disease (775) 775
mortality (733) 733
diabetes mellitus, type 2 - complications (702) 702
risk (690) 690
disease progression (670) 670
adolescent (665) 665
time factors (665) 665
blood-pressure (650) 650
albuminuria - epidemiology (630) 630
cross-sectional studies (630) 630
disease (629) 629
mellitus (603) 603
creatinine - urine (594) 594
glomerular-filtration-rate (587) 587
diabetic nephropathy (584) 584
creatinine - blood (581) 581
hypertension - complications (579) 579
prospective studies (566) 566
rats (566) 566
albuminuria - complications (561) 561
blood pressure - drug effects (540) 540
follow-up studies (536) 536
type 2 diabetes (514) 514
progression (477) 477
chronic kidney-disease (463) 463
albuminuria - diagnosis (460) 460
hypertension - drug therapy (459) 459
blood pressure - physiology (455) 455
renal insufficiency, chronic - physiopathology (452) 452
glycated hemoglobin a - analysis (447) 447
biomarkers - blood (446) 446
chronic kidney disease (445) 445
prognosis (440) 440
kidney diseases (436) 436
nephrology (422) 422
blood glucose - metabolism (417) 417
biomarkers - urine (396) 396
kidney diseases - physiopathology (395) 395
medicine, general & internal (395) 395
diabetes mellitus, type 2 - urine (387) 387
urinary albumin excretion (387) 387
antihypertensive agents - therapeutic use (386) 386
reference values (381) 381
diabetes mellitus (380) 380
child (378) 378
diabetes mellitus, type 1 - complications (377) 377
research (376) 376
diabetes mellitus, type 1 - urine (373) 373
diabetes mellitus, type 2 - blood (370) 370
diabetic nephropathies (369) 369
cohort studies (368) 368
glomerular filtration rate - physiology (368) 368
aged, 80 and over (367) 367
albuminuria - drug therapy (363) 363
diabetic nephropathies - urine (354) 354
risk-factors (353) 353
kidney - drug effects (351) 351
kidney - pathology (351) 351
kidney function tests (344) 344
predictive value of tests (343) 343
body mass index (336) 336
analysis (333) 333
association (330) 330
albuminuria - metabolism (328) 328
medicine & public health (328) 328
diabetic nephropathies - etiology (325) 325
cardiovascular-disease (321) 321
regression analysis (317) 317
care and treatment (313) 313
diabetes mellitus, type 1 - blood (310) 310
kidney (304) 304
albumin (303) 303
glomerular filtration rate - drug effects (299) 299
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5577) 5577
French (65) 65
Japanese (53) 53
Russian (43) 43
German (40) 40
Spanish (30) 30
Chinese (23) 23
Polish (21) 21
Italian (11) 11
Portuguese (10) 10
Czech (9) 9
Romanian (7) 7
Danish (5) 5
Hungarian (5) 5
Serbian (5) 5
Slovak (5) 5
Croatian (4) 4
Dutch (4) 4
Swedish (4) 4
Finnish (2) 2
Norwegian (2) 2
Turkish (2) 2
Bulgarian (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 09/2008, Volume 3, Issue 5, pp. 1430 - 1436
Background and objectives: Lowe syndrome is defined by congenital cataracts, mental retardation, and proximal tubulopathy and is due to mutations in OCRL.... 
OCULOCEREBRORENAL SYNDROME | HYPERCALCIURIA | GENE | HYPOPHOSPHATEMIC RICKETS | TRAFFICKING | UROLOGY & NEPHROLOGY | GLYCOSURIA | MUTATIONS | OCRL1 | FANCONI-SYNDROME | DENT-DISEASE | Oculocerebrorenal Syndrome - genetics | Lysosomal Storage Diseases - physiopathology | Amino Acid Metabolism, Inborn Errors - physiopathology | Humans | Acidosis, Renal Tubular - genetics | Child, Preschool | Oculocerebrorenal Syndrome - complications | Male | Renal Tubular Transport, Inborn Errors - genetics | Nephrocalcinosis - physiopathology | Albuminuria - physiopathology | Amino Acid Metabolism, Inborn Errors - genetics | Fanconi Syndrome - physiopathology | Adult | Female | Hypercalciuria - genetics | Fanconi Syndrome - genetics | Renal Tubular Transport, Inborn Errors - physiopathology | Child | Oculocerebrorenal Syndrome - physiopathology | Glycosuria - physiopathology | Kidney Tubules, Proximal - physiopathology | Phosphoric Monoester Hydrolases - genetics | Glomerular Filtration Rate | Glycosuria - genetics | Europe | Hypercalciuria - physiopathology | Lysosomal Storage Diseases - genetics | Proteinuria - genetics | Proteinuria - physiopathology | Albuminuria - genetics | Phenotype | Nephrocalcinosis - genetics | Hypophosphatemia, Familial - genetics | Adolescent | Hypophosphatemia, Familial - physiopathology | Acidosis, Renal Tubular - physiopathology | Mutation | Hereditary Disease
Journal Article
Diabetes care, ISSN 1935-5548, 2016, Volume 39, Issue Supplement 2, pp. S165 - S171
Diabetic nephropathy (DN) is the most common cause of end-stage renal disease worldwide. Blood glucose and blood pressure control reduce the risk of developing... 
GLUCOSE COTRANSPORTER 2 | DAPAGLIFLOZIN | CANAGLIFLOZIN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | RENAL-DISEASE | GLOMERULAR HYPERFILTRATION | TYPE-2 | NEPHROPATHY | BLOOD-PRESSURE | EMPAGLIFLOZIN | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Kidney Glomerulus - physiopathology | Diabetes Mellitus, Type 1 - complications | Glomerular Filtration Rate - physiology | Albuminuria - physiopathology | Glomerular Filtration Rate - drug effects | Diabetic Nephropathies - physiopathology | Glucosides - therapeutic use | Blood Pressure - drug effects | Blood Pressure - physiology | Benzhydryl Compounds - therapeutic use | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Kidney - physiopathology | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - physiopathology | Kidney - drug effects | Cardiovascular Diseases - metabolism | Diabetes Mellitus, Type 1 - physiopathology | Kidney Failure, Chronic - drug therapy | Kidney Glomerulus - drug effects | Risk Factors | Sodium-Glucose Transporter 2 Inhibitors | Diabetes Mellitus, Type 1 - drug therapy | Diabetes Mellitus, Type 2 - physiopathology | Albuminuria - drug therapy | Diabetes Mellitus, Type 1 - blood | Kidney Failure, Chronic - complications | Renin-Angiotensin System - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10017, pp. 435 - 443
Journal Article
Diabetologia, ISSN 0012-186X, 3/2012, Volume 55, Issue 3, pp. 600 - 607
Endothelial dysfunction is important in the development of vascular complications in diabetes. Patients with type 2 diabetes have increased production of the... 
Type 2 diabetes | Human Physiology | Metabolic Diseases | Internal Medicine | Endothelin receptor antagonist | Bosentan | Medicine & Public Health | Endothelin-1 | Placebo | Randomised controlled trial | Endothelial dysfunction | FMD | Microalbuminuria | Endo-Pat | MECHANISMS | AMPLITUDE | INSULIN-RESISTANCE | DEPENDENT VASODILATATION | DISEASE | ENDOCRINOLOGY & METABOLISM | NITRIC-OXIDE | DYSFUNCTION | BLOCKADE | Albuminuria - complications | Microvessels - physiopathology | Peripheral Vascular Diseases - prevention & control | Humans | Middle Aged | Endothelium, Vascular - drug effects | Male | Hyperemia - prevention & control | Albuminuria - physiopathology | Diabetic Angiopathies - physiopathology | Diabetic Nephropathies - physiopathology | Brachial Artery - physiopathology | Female | Brachial Artery - drug effects | Diabetic Angiopathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Endothelin Receptor Antagonists | Severity of Illness Index | Double-Blind Method | Peripheral Vascular Diseases - physiopathology | Endothelium, Vascular - physiopathology | Microvessels - drug effects | Antihypertensive Agents - therapeutic use | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - physiopathology | Sulfonamides - therapeutic use | Hyperemia - physiopathology | Aged | Vasodilation - drug effects | Albumin | Care and treatment | Endothelin | Endothelium
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2018, Volume 137, Issue 2, pp. 119 - 129
BACKGROUND:Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced cardiovascular morbidity and mortality in patients with type 2 diabetes mellitus... 
Treatment outcome | Hospitalization | Kidney diseases | Mortality | Diabetes mellitus type 2 | Sodiumglucose transporter 2 | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | hospitalization | SAFETY | HEART-FAILURE | sodium-glucose transporter 2 | RISK | DEATH | MECHANISMS | treatment outcome | IMPACT | kidney diseases | mortality | PERIPHERAL VASCULAR DISEASE | diabetes mellitus, type 2 | SGLT2 INHIBITION | PROGRESSION | Prevalence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Cause of Death | Renal Insufficiency, Chronic - drug therapy | Albuminuria - physiopathology | Glomerular Filtration Rate - drug effects | Benzhydryl Compounds - adverse effects | Albuminuria - mortality | Time Factors | Cardiovascular Diseases - mortality | Renal Insufficiency, Chronic - mortality | Female | Glucosides - therapeutic use | Renal Insufficiency, Chronic - diagnosis | Benzhydryl Compounds - therapeutic use | Glucosides - adverse effects | Kidney - physiopathology | Cardiovascular Diseases - diagnosis | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Cardiovascular Diseases - physiopathology | Kidney - drug effects | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Risk Factors | Treatment Outcome | Renal Insufficiency, Chronic - physiopathology | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - physiopathology | Diabetes Mellitus, Type 2 - mortality | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Care and treatment
Journal Article
Circulation, ISSN 0009-7322, 07/2007, Volume 116, Issue 1, pp. 85 - 97
Accelerated cardiovascular disease is a frequent complication of renal disease. Chronic kidney disease promotes hypertension and dyslipidemia, which in turn... 
Hypertension | Kidney | Atherosclerosis | Vasculature | atherosclerosis | vasculature | CARDIAC & CARDIOVASCULAR SYSTEMS | OXIDE SYNTHASE INHIBITION | ENDOTHELIAL DYSFUNCTION | MATRIX GLA PROTEIN | ASYMMETRIC DIMETHYLARGININE | LEFT-VENTRICULAR HYPERTROPHY | CYSTATIN-C CONCENTRATION | kidney | CORONARY-ARTERY CALCIFICATION | END-POINT REDUCTION | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | hypertension | STAGE RENAL-DISEASE | Albuminuria - epidemiology | Kidney Diseases - physiopathology | Oxidative Stress | Calcium - metabolism | Cardiovascular Diseases - prevention & control | Humans | Arginine - analogs & derivatives | Atherosclerosis - etiology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Calcinosis - etiology | Kidney Diseases - epidemiology | Cystatin C | Inflammation Mediators - metabolism | Cardiovascular Diseases - epidemiology | Kidney Diseases - complications | Dyslipidemias - etiology | Bone Resorption - etiology | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Glomerular Filtration Rate | Diabetes Complications - physiopathology | Atherosclerosis - physiopathology | Risk Factors | Endothelium, Vascular - physiopathology | Hypertension, Renal - etiology | Renin-Angiotensin System - physiology | Clinical Trials as Topic | Cystatins - blood | Disease Progression | Phosphates - metabolism | Animals | Dogs | Biomarkers | Creatinine - blood | Chronic Disease | Arginine - metabolism | Calcinosis - physiopathology | Cohort Studies | Cardiovascular system | Prevention | Complications and side effects | Care and treatment | Physiological aspects | Development and progression | Kidney diseases | Research | Cardiovascular diseases | Cardiopulmonary system | Risk factors
Journal Article
Kidney International, ISSN 0085-2538, 2010, Volume 78, Issue 11, pp. 1136 - 1153
The remnant kidney model in C57BL/6 mice does not develop progressive chronic kidney disease (CKD). In this study we modified the model to mimic features of... 
blood pressure | telemetry | glomerulosclerosis | interstitial fibrosis | angiotensin II | ARTERIAL-BLOOD-PRESSURE | PRACTICE GUIDELINES | LOW-BIRTH-WEIGHT | 9 GENE MYH9 | CARDIAC-HYPERTROPHY | DISEASE | UROLOGY & NEPHROLOGY | RECEPTOR ACTIVATION | HYPERTENSION | CHRONIC-RENAL-FAILURE | MOLECULAR-MECHANISMS | Blood Pressure | Kidney Diseases - physiopathology | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Angiotensin II - administration & dosage | Kidney - pathology | Species Specificity | Hydralazine - pharmacology | Hypertension - drug therapy | Male | Mice, 129 Strain | Angiotensin II Type 1 Receptor Blockers - pharmacology | X-Ray Microtomography | Kidney Diseases - genetics | Hypertension - etiology | Anemia - physiopathology | Albuminuria - physiopathology | Nephrectomy | Time Factors | Glomerulonephritis - etiology | Hypertension - genetics | Glomerulonephritis - physiopathology | Anemia - etiology | Kidney - physiopathology | Disease Models, Animal | Genetic Predisposition to Disease | Infusion Pumps, Implantable | Kidney - drug effects | Albuminuria - etiology | Heart Diseases - physiopathology | Kidney Diseases - pathology | Kidney Diseases - prevention & control | Mice, Inbred C57BL | Desoxycorticosterone | Imidazoles - pharmacology | Sodium Chloride, Dietary | Telemetry | Disease Progression | Hypertension - pathology | Hypertension - physiopathology | Infusions, Subcutaneous | Heart Diseases - etiology | Animals | Fibrosis | Mice | Kidney Diseases - etiology | Blood Pressure Monitoring, Ambulatory | Chronic Disease
Journal Article